StemEdit™ Gene Edited iPSCs

Brand: StemEdit™ by Stemgent® (REPROCELL®)

High-quality HLA knockout iPSC lines developed using our state-of-the-art genome editing technology, utilizing a proprietary nuclease system. is also well-suited for clinical gene-editing projects.

NOTE: These iPSC Cell Lines are developed for Research Use Only. They are NOT suitable for use in Clinical Projects.

Off-the-shelf iPSCs suitable for clinical use are also available. Please see Clinical Stem Cell Services or Contact Us for more information.

Products:

StemEdit™ Human iPSC non-HLA class 1/2 (B2M/CIITA Homo double KO)

Brand: StemEdit™

RCRP043E

Human iPSCs with Knockouts in the B2M (HLA Class I) and CIITA (HLA Class II) genes.

StemEdit™ Human iPSC non-HLA class 1/2 (B2M/CIITA Homo double KO)

StemEdit™ Human iPSC non-HLA class 1 (B2M Homo KO)

Brand: StemEdit™

RCRP044E

Human iPSCs with a Knockout in the B2M (HLA Class I) gene